424B3FORM 424B3
Jun 1, 2026Final prospectus0001437749-26-019043
All companies
424B4May 6, 2026
Picard Medical Inc
PMIPublicArchived
Public / ArchivedUnited States(NYSE)Best valuation $18.93M1 market
Public listing
Listed· NYSE· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: SEC EDGAR, Nasdaq
IPO Calendar · NYSEIPO
PMIPrice
$7.70
24h
-1.03%
Valuation
$18.93M
24h volume
$757.4K
Type
IPO
IPO Calendar · updated 2h ago
Picard Medical Inc IPO public float & lock-up
Public float and locked shares extracted from Picard Medical Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
92.04M
Public float
16.67M
Locked
75.38M
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0002030617.
Revenue · +12.50% YoY
$4.94M
Net income
-$27M
Gross margin
-4.13%
Cash
$7.45M
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $4.94M | $4.39M | — |
| Gross profit | -$204K | -$112K | — |
| Operating income | -$13.26M | -$13.71M | — |
| Net income | -$27M | -$21.06M | — |
| R&D expense | $3.05M | $3.38M | — |
| Cash & equivalents | $7.45M | $96K | — |
| Total assets | $22.55M | $12.11M | — |
| Total liabilities | $18.76M | $35.84M | — |
| Shareholders' equity | $3.79M | -$44M | -$23.82M |
About Picard Medical Inc
Picard Medical is a medical technology company focused on total artificial heart systems through its SynCardia subsidiary.
What the company does
- Develops, manufactures, and commercializes the SynCardia Total Artificial Heart for patients with advanced or end-stage heart failure.
- Supports hospital-based and portable driver systems used with total artificial heart therapy.
- Works in a specialized cardiovascular device market that requires surgical training, clinical support, regulatory compliance, and manufacturing reliability.
Business profile
Picard Medical operates in medical devices, where clinical outcomes, regulatory approvals, physician adoption, reimbursement, and post-implant support are central.
SEC IPO filings
Final prospectusEDGAR filings resolved from PMI / CIK 0002030617.
May 29, 2026Effective9999999995-26-001814
CORRESPfilename1.htm
May 27, 2026SEC correspondence0001437749-26-018559
UPLOADfilename1.pdf
May 26, 2026SEC correspondence0000000000-26-005353
S-1FORM S-1
May 20, 2026Filed0001437749-26-017949
424B4424B4
May 6, 2026Final prospectus0001829126-26-004627
May 4, 2026Effective9999999995-26-001481
CORRESPfilename1.htm
May 4, 2026SEC correspondence0001829126-26-004417
CORRESPfilename1.htm
May 4, 2026SEC correspondence0001829126-26-004415
S-1/AS-1/A
May 1, 2026Amended0001829126-26-004376
CORRESPfilename1.htm
Apr 30, 2026SEC correspondence0001829126-26-004278
CORRESPfilename1.htm
Apr 30, 2026SEC correspondence0001829126-26-004277
Picard Medical Inc IPO — frequently asked questions
- When did Picard Medical Inc go public?
- Picard Medical Inc has already gone public and now trades publicly on NYSE under the ticker PMI.
- Can I buy Picard Medical Inc stock?
- Yes — Picard Medical Inc is publicly traded on NYSE as PMI. You can follow its live price, valuation and post-IPO performance above.
- What is Picard Medical Inc's valuation?
- Picard Medical Inc's most recent valuation tracked here is $18.93M, derived from live market prices.